Read + Share
. Correction to "Retrospective analysis of cutaneous immune-related adverse events
following checkpoint inhibitor therapy in melanoma patients reveals increased
risk associated with the HLA-B*51:01 allele". Cancer 2026;132:e70350.
PMID: 41855079
|
 |
|
